Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Benzylpyridinium >  Indibulin

Indibulin

Basic information Safety Supplier Related

Indibulin Basic information

Product Name:
Indibulin
Synonyms:
  • 2-[1-[(4-chlorophenyl)methyl]indol-3-yl]-2-oxo-N-pyridin-4-ylacetamide
  • Nascapine
  • ZIO 301
  • 2-(1-(4-Chlorophenylmethyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide
  • Indibulin
  • 2-[1-(4-Chlorobenzyl)-1H-indol-3-yl]-2-oxo-N-pyridin-4-ylacetamide
  • lindiblin
  • 1H-Indole-3-acetamide, 1-[(4-chlorophenyl)methyl]-α-oxo-N-4-pyridinyl-
CAS:
204205-90-3
MF:
C22H16ClN3O2
MW:
389.83
Product Categories:
  • Anticancer.
Mol File:
204205-90-3.mol
More
Less

Indibulin Chemical Properties

Density 
1.31±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,Store in freezer, under -20°C
solubility 
DMSO:33.25(Max Conc. mg/mL);85.29(Max Conc. mM)
form 
A solid
pka
9.38±0.70(Predicted)
color 
Off-white to yellow
More
Less

Indibulin Usage And Synthesis

Description

Indibulin (D-24851; ZIO-301), a novel synthetic small molecule microtubule inhibitor, destabilizes microtubules and has antitumor activity but does not exhibit neurotoxicity in preclinical animal studies. Indibulin reduces inter-kinetochoric tension, produces aberrant spindles, activates mitotic checkpoint proteins Mad2 and BubR1, and induces mitotic arrest and apoptosis. The drug can discriminate between highly posttranslationally modified tubulin present in mature neuronal microtubules, and less-modified tubulin present in immature neuronal or nonneuronal microtubules.

Uses

Indibulin is a chemotherapeutic drug that destabilizes microtubules and is used to treat aggressive and heterogenous cancers, including breast cancer.

Biological Activity

Indibulin is a microtubule destabilizer that blocks tubulin polymerization (IC50 = 0.3 μM). Blocks cell cycle progression at metaphase and displays antitumor activity against a variety of malignancies in vitro (IC50 values ranging from 0.036 - 0.285 μM). Induces complete tumor remission in the Yoshida AH13 rat sarcoma model in vivo. Lacks neurotoxicity due to an ability to discriminate between posttranslationally modified tubulin in mature neuronal microtubules and less-modified tubulin present in immature neuronal or nonneuronal microtubules. Displays oral availability and efficacy towards MDR tumor cells.

storage

Desiccate at -20°C

Mode of action

Indibulin binds to a site on tubulin that is different from taxane- or Vinca alkaloid-binding sites, destabilizing tubulin polymerization and inducing tumor cell cycle arrest and apoptosis. This agent has been shown to be active against multidrug-resistant (MDR) and taxane- resistant tumor cell lines.

References

Indibulin, a Novel Microtubule Inhibitor, Discriminates between Mature Neuronal and Nonneuronal Tubulin
https://www.rndsystems.com/products/indibulin_3728
https://pubchem.ncbi.nlm.nih.gov/compound/2929

IndibulinSupplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
ZHIWE CHEMTECH CO LTD
Tel
021-20221225 13917446399
Email
sales@zhiwe.net
VDM Biochemicals
Tel
0330-2528181
Email
sales@vdmbio.com
Finetech Industry Limited
Tel
027-87465837 19945049750
Email
sales@finetechnology-ind.com
Shanghai Balmxy Pharmaceutical Co., Ltd
Tel
021-24206007 13764915196
Email
sales@balmxy.com